LEXX Stock Earnings: Lexaria Bioscience Misses EPS, Misses Revenue for Q3 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

LEXX stock results show that Lexaria Bioscience missed analyst estimates for earnings per share and missed on revenue for the third quarter of 2024.

The post LEXX Stock Earnings: Lexaria Bioscience Misses EPS, Misses Revenue for Q3 2024 appeared first on InvestorPlace.

More From InvestorPlace

• Legendary Investor Predicts: “Forget A.I. THIS Technology Is the Future”